Javascript must be enabled to continue!
P4678The hemodynamic improvement with balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension depends on the lesion location
View through CrossRef
Abstract
Background
Pulmonary endarterectomy (PEA) is a treatment of choice for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Patients with proximal pulmonary artery disease are considered to be good candidates for PEA because of their generally excellent outcomes. However, not all patients can be operated because of patients' advanced age, comorbidities and poor general condition. Balloon pulmonary angioplasty (BPA) has become an alternative treatment for CTEPH patients especially whose lesions locate in the distal site. The effectiveness of BPA in patients who have lesions in the proximal pulmonary arteries but cannot be a candidate for PEA remains unclear.
Purpose
The aim of this study was to investigate the outcome of BPA in CTEPH patients whose lesions appears operable but ineligible for PEA.
Methods
A total of 370 patients who underwent BPA in our institute from November 2004 to January 2018 were enrolled. All the patients were divided into operable group and inoperable group according to the difference of lesion location based on the findings of perfusion scintigraphy, computed tomography and pulmonary angiography. Hemodynamic effects of BPA in both groups were investigated. We also conducted survival analyses using the Kaplan-Meier method with the log-rank test.
Results
Among 370 patients, 90 patients deemed operable. The main reasons why not operated in the PEA operable group were patient's refusal (44%), advanced age (14%), and comorbidities (27%). There were no baseline characteristic differences between two groups except for the history of acute pulmonary embolism. Mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) equally improved after BPA in both groups (operable: 38.2±10.8 mmHg to 21.5±4.7mmHg, inoperable: 42.4±11.3 mmHg to 21.8±4.8 mmHg, p<0.001, operable: 8.0±4.2 wood unit to 3.5±1.5 wood unit, inoperable: 9.1±4.6 wood unit to 3.4±1.3 wood unit, p<0.001). Furthermore, five-year cumulative survival rates were not different between two groups (inoperable vs. operable: 93% vs. 88%, p=0.23, median follow-up period was 23.0 months (range: 5–136 months)). Meanwhile, the absolute change of mPAP and PVR in inoperable group were greater than those in operable group (inoperable: 20.7±11.2 mmHg, operable: 16.6±11.0 mmHg, p=0.010, inoperable: 5.6±4.4 wood unit, operable: 4.5±3.9 wood unit, p=0.015).
Conclusions
Although the outcome of BPA for CTEPH patients with operable lesions appears acceptable, absolute change in hemodynamics was lower than that of the patients with inoperable lesions. CTEPH with proximal lesions should be treated with PEA rather than BPA.
Oxford University Press (OUP)
Title: P4678The hemodynamic improvement with balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension depends on the lesion location
Description:
Abstract
Background
Pulmonary endarterectomy (PEA) is a treatment of choice for patients with chronic thromboembolic pulmonary hypertension (CTEPH).
Patients with proximal pulmonary artery disease are considered to be good candidates for PEA because of their generally excellent outcomes.
However, not all patients can be operated because of patients' advanced age, comorbidities and poor general condition.
Balloon pulmonary angioplasty (BPA) has become an alternative treatment for CTEPH patients especially whose lesions locate in the distal site.
The effectiveness of BPA in patients who have lesions in the proximal pulmonary arteries but cannot be a candidate for PEA remains unclear.
Purpose
The aim of this study was to investigate the outcome of BPA in CTEPH patients whose lesions appears operable but ineligible for PEA.
Methods
A total of 370 patients who underwent BPA in our institute from November 2004 to January 2018 were enrolled.
All the patients were divided into operable group and inoperable group according to the difference of lesion location based on the findings of perfusion scintigraphy, computed tomography and pulmonary angiography.
Hemodynamic effects of BPA in both groups were investigated.
We also conducted survival analyses using the Kaplan-Meier method with the log-rank test.
Results
Among 370 patients, 90 patients deemed operable.
The main reasons why not operated in the PEA operable group were patient's refusal (44%), advanced age (14%), and comorbidities (27%).
There were no baseline characteristic differences between two groups except for the history of acute pulmonary embolism.
Mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) equally improved after BPA in both groups (operable: 38.
2±10.
8 mmHg to 21.
5±4.
7mmHg, inoperable: 42.
4±11.
3 mmHg to 21.
8±4.
8 mmHg, p<0.
001, operable: 8.
0±4.
2 wood unit to 3.
5±1.
5 wood unit, inoperable: 9.
1±4.
6 wood unit to 3.
4±1.
3 wood unit, p<0.
001).
Furthermore, five-year cumulative survival rates were not different between two groups (inoperable vs.
operable: 93% vs.
88%, p=0.
23, median follow-up period was 23.
0 months (range: 5–136 months)).
Meanwhile, the absolute change of mPAP and PVR in inoperable group were greater than those in operable group (inoperable: 20.
7±11.
2 mmHg, operable: 16.
6±11.
0 mmHg, p=0.
010, inoperable: 5.
6±4.
4 wood unit, operable: 4.
5±3.
9 wood unit, p=0.
015).
Conclusions
Although the outcome of BPA for CTEPH patients with operable lesions appears acceptable, absolute change in hemodynamics was lower than that of the patients with inoperable lesions.
CTEPH with proximal lesions should be treated with PEA rather than BPA.
Related Results
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
P885 Pulmonary artery stent implantation in an adult with chronic thromboembolic pulmonary stenosis
P885 Pulmonary artery stent implantation in an adult with chronic thromboembolic pulmonary stenosis
Abstract
Introduction
Pulmonary artery stenosis presenting in adults is rare. Chronic thromboembolic pulmonary hypertension (CTE...
Chronic thromboembolic pulmonary hypertension: at the heart of the pulmonary arteries
Chronic thromboembolic pulmonary hypertension: at the heart of the pulmonary arteries
Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term consequence of acute pulmonary embolism (PE) and is frequently diagnosed at an advanced stage. It...
Haemodynamic and Clinical Impacts of Switching Phosphodiesterase-5 Inhibitors to Riociguat in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after Balloon Pulmonary Angioplasty (BPA) – A Prospective Cohort Study
Haemodynamic and Clinical Impacts of Switching Phosphodiesterase-5 Inhibitors to Riociguat in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after Balloon Pulmonary Angioplasty (BPA) – A Prospective Cohort Study
Abstract
Background
For patients with chronic thromboembolic pulmonary hypertension (CTEPH), balloon pulmonary angioplasty (BPA) has been associated with superior reduction...
526 ALAGILLE SYNDROME, A CASE REPORT
526 ALAGILLE SYNDROME, A CASE REPORT
Abstract
Alagille syndrome (AGS) is a dominantly inherited multisystem disorder caused by heterozygous mutations of genes that are components of the Notch signaling ...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Cutting Balloon Angioplasty and Stent Implantation for Aorto‐ostial Lesions: Clinical Outcome and 1‐year Follow‐up
Cutting Balloon Angioplasty and Stent Implantation for Aorto‐ostial Lesions: Clinical Outcome and 1‐year Follow‐up
AbstractBackgroundPercutaneous interventions for aorto‐ostial narrowing of native coronary arteries are challenging because of early elastic recoil after the procedure and the high...

